(Q73683996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Where next with stem-cell-supported high-dose therapy for breast cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

J Bergh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

944-945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

9208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990007-2

7 January 2021

10.1016/S0140-6736(00)90007-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10768427%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference